Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02369497 · ClinicalTrials.gov registry record
Ascension® Humeral Resurfacing Arthroplasty (HRA) Follow-Up Study
A clinical trial, sponsored by Integra LifeSciences Corporation.
- Terminated
- Registry status
- 59
- Enrollment target
NCT02369497 is a clinical trial that was terminated before completion, run by Integra LifeSciences Corporation. The registered enrollment target is 59 participants.
The verdict
NCT02369497 was terminated before completion, sponsored by Integra LifeSciences Corporation.
- TERMINATED
- Registry status
- 59 participants
- Enrollment target
Study Summary
This is a prospective study on the Ascension HRA device to collect data to assess the safety and effectiveness of the HRA.
Interventions
- DEVICE HRA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2007-12 |
| Est. Completion | 2014-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02369497
The ClinicalTrials.gov registry entry for NCT02369497 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 59 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Integra LifeSciences Corporation, which has 60 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which HRA is the first listed.
NCT02369497 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02369497 about?
NCT02369497 is a clinical study titled "Ascension® Humeral Resurfacing Arthroplasty (HRA) Follow-Up Study". This is a prospective study on the Ascension HRA device to collect data to assess the safety and effectiveness of the HRA.
What is the current status of trial NCT02369497?
This trial is currently terminated. The enrollment target is 59 participants. The study started on 2007-12. Estimated completion is 2014-07.
What interventions are being tested in trial NCT02369497?
The interventions under investigation include: HRA (DEVICE).
Who is sponsoring clinical trial NCT02369497?
This trial is sponsored by Integra LifeSciences Corporation, which has 60 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.